DaVita Inc. (DVA) Shares Drop Over 6% Amid New Kidney Care Plan Announcement

gurufocus.com · 2026-10-20

On October 20, 2026, DaVita Inc. (NYSE: DVA) saw its stock price decline by more than 6%, closing at $175.35, following news of a proposed Kidney Care National

TickrTrends take: DaVita's recent share decline creates a potential disconnect between market reaction and TickrTrends' undervalued assessment, suggesting investors may be overweighting near-term uncertainty around the kidney care plan announcement. A valuation-focused investor should monitor whether this pullback reflects genuine deterioration in the company's fundamental earnings power or represents an overreaction that could present a valuation opportunity in the healthcare sector. The divergence between the stock's price movement and the valuation signal warrants attention to how the market reassesses DVA's competitive positioning and profitability as details around the new kidney care plan emerge.

Read the full story at gurufocus.com →